Mycoplasma Testing Market worth $613.49 Million by 2019

1
MarketsandMarkets Presents
Mycoplasma Testing Market worth 613.49 Million
by 2019
2

• The report Mycoplasma Testing Market by Products
  (Instruments, Kits Reagents, Services),
  Application (Cell Line, Virus, End of Production
  Cells), Technology (PCR, ELISA, Direct Assay),
  End User (Cell Banks, Pharmaceutical Companies) -
  Global Forecast to 2019, is expected to reach
  613.49 Million by 2019 from 340.29 Million in
  2014, growing at a CAGR of 12.51 between 2014
  and 2019.
• Browse 74 market data tables and 103 figures
  spread through 175 pages and in-depth TOC on
  Mycoplasma Testing Market by Products
  (Instruments, Kits Reagents, Services),
  Application (Cell Line, Virus, End of Production
  Cells), Technology (PCR, ELISA, Direct Assay),
  End User (Cell Banks, Pharmaceutical Companies) -
  Global Forecast to 2019"
• http//www.marketsandmarkets.com/Market-Reports/my
  coplasma-testing-market-136509856.html

3

Early buyers will receive 10 customization on
Reports.
4

• The report provides a detailed overview of the
  major drivers, restraints, challenges,
  opportunities, current market trends, and
  strategies impacting the global mycoplasma
  testing market along with the estimates and
  forecasts of the revenue and market share
  analysis.
• The global market is poised for rapid growth
  between 2014 and 2019. The growth in
  pharmaceutical industry and government funding
  for drug discovery and life sciences are
  important reasons for the growth in market size.
• Increasing number of biotechnology
  pharmaceutical companies will also aid the growth
  of the mycoplasma testing market. Today, The
  global biopharmaceutical revenues in 2014 are
  estimate to be 163 Billion, contributing to
  about 20 of the pharmaceutical market. It is the
  fastest growing area of the industry

5

• According to estimates from the IMS Institute of
  Healthcare Informatics, the global pharmaceutical
  industry is expected to grow at a CAGR between 7
  and 12 in the forecast period (2014 to 2019).
  The Asia-Pacific region is expected to witness
  the highest CAGR in this industry growth rates
  are expected to be as high as 11 to 14 in
  emerging markets. This high growth rate, along
  with the substantial size of RD spending on drug
  discovery projects, will act as an important
  driver of the mycoplasma testing market.
• The major players in the mycoplasma testing
  market include Merck KGaA (U.S.), Sigma-Aldrich
  (U.S.), Thermo Fisher Scientific (U.S.), Lonza
  Group Ltd. (Switzerland), Charles River
  Laboratories International, Inc. (U.S.), Promo
  Cell GmbH (Germany), Bionique Testing
  Laboratories, Inc.(France), American Type Culture
  Collection (U.S.), InvivoGen.(U.S.), Biological
  Industries Israel Beit Haemek Ltd. (Israel) and
  others.

6
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
7
Contact Us
Mr. RohanMarkets and Markets UNIT no 802, Tower
no. 7, SEZ Magarpatta city, Hadapsar Pune,
Maharashtra 411013, India 1-888-600-6441 Email
sales_at_marketsandmarkets.com Visit
MarketsandMarkets Blog _at_ http//mnmblog.org/market
-research/healthcare/medical-devices Connect
with us on LinkedIn _at_ http//www.linkedin.com/comp
any/marketsandmarkets